Un mode de conduite biologique et un niveau élevé d'herbe améliorent la qualité nutritionelle des acides gras de la viande chez l'agneau engraisse au pâturage

This study aimed at comparing the nutritional quality of meat fatty acids (FA) of pasture-fed lambs reared organically or conventionally and offered two levels of herbage availability. Forty eight castrated male lambs of Limousine breed were used in a 2 x 2 experimental design, i.e. production system (Organic –O- vs. Conventional –C-) x level of herbage availability (High vs. Low). The O and C pastures differed in the level of on-pasture mineral N fertilization (0 vs. 100 U. ha-1. year-1) since 10 years. The level of pasture availability was managed to obtain a mean lamb age at slaughter of 5 vs. 6 months in the High and the Low level respectively. GLC analysis of fatty acids from the Longissimus thoracis muscle showed that organic farming system improved the health value of lamb meat by decreasing the level of saturated FA and especially 16:0, thus leading to a higher value of polyunsaturated FA (PUFA) to saturated FA ratio (+15%, P<0.03) and increasing the level of CLA (+18.2%, P< 0.002). The high level of herbage availability led to a better nutritional and health value of meat FA by increasing significantly deposition of n-6 PUFA (+16.3%), n-3 PUFA (+15%) and CLA (+20.2%) in LT muscle to the detriment of saturated FA (-3.4%). In conclusion, the present study confirmed the general interest of pasture-feeding on the nutritional quality of the lamb meat. It showed, for the first time, the beneficial impact of organic farming on the health value of lamb meat FA by favouring deposition of PUFA (compared to saturated FA) and CLA, this effect being reinforced by a high level of pasture availability

Qualités de la viande d’agneaux d’herbe produits en élevage biologique ou conventionnel

La mention "Agriculture Biologique" sur un produit garantit une manière de produire, mais l’obligation de résultats est limitée à la conformation et l’état d’engraissement de la carcasse, d’où des questions sur les qualités alimentaires du produit viande

Comparison of the meat and carcass quality of lambs raised in organic or conventional production systems.

The ‘organic’ label on a product guarantees that synthetic fertilisers, pesticides and hormones are not used in the production process and that the use of pharmaceutical products and drugs is limited. However, product quality is often questioned and we have to anticipate the consumer demand for product quality guarantees. This study was conducted to compare the sensory and nutritional meat and carcass qualities of lambs raised under an organic (O) or a conventional (C) production system. Comparisons were made with both pasture-fed lambs and lambs that were stall-fed indoors with concentrate and hay. The experiment was conducted over two years for stall-fed lambs (S) (group O, n=24; group C, n=24) and three years for pasture-fed lambs (P) (group O, n=36; group C, n=36). For P lambs, O and C production systems differed in terms of the level of mineral N fertilisation of the pasture. For S lambs, the feed was organic vs. conventional, and the ingredients of O and C concentrates were the same. The nutritional quality of the meat (longissimus dorsi) was assessed in terms of its fatty acid (FA) composition, and the sensory quality of the loin chop was assessed by a trained sensory panel. In stall-fed lambs, the health value of meat FA for human consumption was higher in the O group than in the C group, but there was no difference in the sensory quality of the meat and the carcass between the O and C groups. In pasture-fed lambs, there were no significant differences between the O and C groups in terms of the health value of meat FA. However, in pasture-fed lambs, the loin chops had a higher level of abnormal odour of the fat in the organic than in the conventional group, probably due to a higher proportion of white clover in the diet

Phylogenetic Group –Associated Differences in Regulation of the Common Colonization Factor Mat Fimbria in Escherichia coli

Peer reviewe

La viande du futur sera-t-elle produite in vitro ?

La production de viande artificielle par culture de cellules est proposée par certains scientifiques comme une des solutions pour répondre aux grands enjeux de l’élevage : i) réduire le mal-être supposé des animaux dans les élevages modernes, voire ne pas tuer les animaux pour les manger, ii) réduire la possible dégradation de l’environnement par l’élevage et iii) réduire la faim dans le monde en augmentant le niveau des ressources protéiques alimentaires. La viande artificielle supprimerait en effet le mal-être supposé des animaux lié à l’élevage et permettrait de ne pas abattre les animaux pour les manger. L’impact environnemental de la viande artificielle est difficile à évaluer en l’absence de données sur le fonctionnement d’une usine de production. La viande artificielle présenterait toutefois un intérêt modéré pour réduire les gaz à effet de serre et la pollution par les nitrates, un intérêt limité quant à l’utilisation des énergies fossiles, voire très limité pour limiter les besoins en eau, mais elle libérerait des terres cultivables. Elle entraînerait probablement dans l’eau des résidus de molécules de synthèse. De nombreux experts estiment que les causes de la malnutrition actuelle de certaines populations sont multiples et ne sont pas directement liées à un manque de ressources alimentaires. Bien que la culture de cellules soit couramment pratiquée en laboratoire, il existe des verrous techniques importants à lever pour une production à grande échelle, tels que le coût rédhibitoire des technologies actuelles et le manque de ressemblance du produit obtenu à de la viande issue d’animaux. Sur le plan nutritionnel, la viande artificielle ne présente pas d’avantage particulier par rapport à un autre aliment élaboré à partir de l’ensemble des nutriments nécessaires à sa production. Les critères d’acceptabilité de la viande artificielle renvoient, d’une part, à des questions d’ordre moral ou éthique concernant la technologie et les inquiétudes qu’elle soulève, et d’autre part, à des considérations classiques relatives aux produits alimentaires (prix, qualité, naturalité...). Par le passé, les expériences de substitution des protéines animales par des produits analogues ont échoué en raison, notamment, de contraintes économiques, du temps nécessaire pour l’éventuelle acceptation des produits par les consommateurs et pour la délivrance des autorisations de mise sur le marché. Face aux questionnements importants concernant l’élevage, la production de viande artificielle ne présente pas aujourd’hui d’avantages majeurs par comparaison à la viande naturelle ou à d’autres alternatives possibles telles que rééquilibrer notre alimentation en diversifiant les sources de protéines végétales et animales, ou encore développer des systèmes d’élevage plus respectueux des animaux et de l’environnement

The role of dietary methionine concentrations on growth, metabolism and N-retention in cobia (Rachycentron canadum) at elevated water temperatures

This study determined impacts of dietary methionine concentrations at two temperatures on growth, feeding efficiency and N-metabolites in juvenile cobia. Methionine concentrations of the experimental diets were deficient (M9; 9 g/kg), sufficient (M12; 12 g/kg) and surplus (M16, 16 g/kg). Water temperature was normal (30°C) or elevated (34°C). Twenty cobia in triplicate tanks were fed the experimental diets for 6 weeks. Both methionine and temperature affected cobia's growth and feeding efficiency. Cobia fed M9 performed lower than the fish fed M12 and M16 diets. Additionally, cobia reared at 34°C performed poorer than at 30°C, probably due to lower voluntary feed intake in the fish reared at 34°C. Protein efficiency ratio and protein productive value in cobia fed M9 diet were less than M12 or M16 diets. This was confirmed with the improved retentions of indispensable amino acids (AAs). No interactions between methionine and temperature were observed in growth and protein accretion. At 30°C, CF improved, while HSI and VSI declined upon methionine supplementation levels. Of which an interaction between temperature and methionine was present. Plasma, muscle and liver free AA and N-metabolites were affected by methionine and temperature. Furthermore, temperature affected cobia's lipid class composition, resulting in increased phospholipids and cholesterol at 34°C.Agência financiadora / Código de projetos European Union's H2020 Programme 691150 MINECO Spain project EFISHDIGEST AGL2014-52888 European Social Fund FCT IF/00482/2014/CP1217/CT0005 National Funds through FCT CCMAR/Multi/04326/2013 Norwegian Agency for Development Cooperation NORHED QZA-0485 SRV-13/0010info:eu-repo/semantics/publishedVersio

Sequencing and functional annotation of avian pathogenic Escherichia coli serogroup O78 strains reveals the evolution of E. coli lineages pathogenic for poultry via distinct mechanisms

Avian pathogenic Escherichia coli (APEC) causes respiratory and systemic disease in poultry. Sequencing of a multilocus sequence type 95 (ST95) serogroup O1 strain previously indicated that APEC resembles E. coli causing extraintestinal human diseases. We sequenced the genomes of two strains of another dominant APEC lineage (ST23 serogroup O78 strains χ7122 and IMT2125) and compared them to each other and to the reannotated APEC O1 sequence. For comparison, we also sequenced a human enterotoxigenic E. coli (ETEC) strain of the same ST23 serogroup O78 lineage. Phylogenetic analysis indicated that the APEC O78 strains were more closely related to human ST23 ETEC than to APEC O1, indicating that separation of pathotypes on the basis of their extraintestinal or diarrheagenic nature is not supported by their phylogeny. The accessory genome of APEC ST23 strains exhibited limited conservation of APEC O1 genomic islands and a distinct repertoire of virulence-associated loci. In light of this diversity, we surveyed the phenotype of 2,185 signature-tagged transposon mutants of χ7122 following intra-air sac inoculation of turkeys. This procedure identified novel APEC ST23 genes that play strain- and tissue-specific roles during infection. For example, genes mediating group 4 capsule synthesis were required for the virulence of χ7122 and were conserved in IMT2125 but absent from APEC O1. Our data reveal the genetic diversity of E. coli strains adapted to cause the same avian disease and indicate that the core genome of the ST23 lineage serves as a chassis for the evolution of E. coli strains adapted to cause avian or human disease via acquisition of distinct virulence genes

Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the Erythropoietin in Myocardial Infarction Trial

Background Preclinical studies and pilot clinical trials have shown that high-dose erythropoietin (EPO) reduces infarct size in acute myocardial infarction. We investigated whether a single high-dose of EPO administered immediately after reperfusion in patients with ST-segment elevation myocardial infarction (STEMI) would limit infarct size. Methods A total of 110 patients undergoing successful primary coronary intervention for a first STEMI was randomized to receive standard care either alone (n = 57) or combined with intravenous administration of 1,000 U/kg of epoetin β immediately after reperfusion (n = 53). The primary end point was infarct size assessed by gadolinium-enhanced cardiac magnetic resonance after 3 months. Secondary end points included left ventricular (LV) volume and function at 5-day and 3-month follow-up, incidence of microvascular obstruction (MVO), and safety. Results Erythropoietin significantly decreased the incidence of MVO (43.4% vs 65.3% in the control group, P = .03) and reduced LV volume, mass, and function impairment at 5-day follow-up (all P &lt; .05). After 3 months, median infarct size (interquartile range) was 17.5 g (7.6-26.1 g) in the EPO group and 16.0 g (9.4-28.2 g) in the control group (P = .64); LV mass, volume, and function were not significantly different between the 2 groups. The same number of major adverse cardiac events occurred in both groups. Conclusions Single high-dose EPO administered immediately after successful reperfusion in patients with STEMI did not reduce infarct size at 3-month follow-up. However, this regimen decreased the incidence of MVO and was associated with transient favorable effects on LV volume and function